-
Clinical Research Organization's (CROs) using Artificial Intelligence (AI) tools in restructuring the clinical trials
Shruti Talashi
April 11, 2024
Healthcare is embracing AI for better diagnosis, drug development, and patient care.
-
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research
Biotech Newswire
April 07, 2024
The Application of Knowledge Engineering via the use of a Biomimetic Digital Twin Ecosystem, Phenotype DrivenVariant Analysis, and Exome Sequencing to Understand the Molecular Mechanisms of Disease.
-
The Transformative Role of Generative AI (genAI) in the Pharmaceutical Industry
David Orchard-Webb
April 01, 2024
The future of genAI in pharmaceuticals is bright, promising a healthier, more efficient approach to drug development and patient care.
-
ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology
Biotech Newswire
March 15, 2024
This collaborative effort will leverage ProBioGen's cutting-edge GlymaxX® technology to enhance the therapeutic potential of the antibody by adjusting the afucosylation levels.
-
Joining Forces with Zai Lab: What is the Remaining Market Potential for Opdivo in China?
Yefenghong
March 06, 2024
Bristol Myers Squibb (BMS) recently announced the transfer of sales rights for one of its core products, the PD-1 monoclonal antibody Opdivo (nivolumab), in select provinces within China to the local biotechnology firm Zai Lab Limited (ZLAB).
-
The Narrative of Pharmaceuticals Bestowed with Endorsement and Later Reclaimed by Oblivion by the FDA
zhulikou431
March 06, 2024
This document endeavors to compile and elucidate data pertaining to instances where the U.S. FDA, in recent years, has rescinded market approval for pharmaceuticals previously sanctioned.
-
Making drug manufacturing carbon neutral throughout the supply chain
Suzanne Elvidge
March 04, 2024
In 2015, at the United Nations Climate Change Conference (COP21), 196 countries adopted the Paris Agreement to limit global warming to no more than 1.5 °C.
-
How could AI change drug development by ChatGPT
PharmaSources
February 26, 2024
Artificial Intelligence (AI) has the potential to significantly impact and revolutionize the field of drug development in several ways.
-
The Evolving Landscape of Heart Failure Therapies
Neeta Ratanghayra
January 31, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.
-
German Company FUSE-AI Launches Groundbreaking AI Algorithm for Radiology to the Market
B3C newswire
January 29, 2024
As of January 2024, the company is authorized to distributeits software as a medical product.